These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 309134)

  • 1. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor.
    Read MS; Shermer RW; Brinkhous KM
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4514-8. PubMed ID: 309134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of venom coagglutinin and lyophilized platelets in testing for platelet-aggregating von Willebrand factor.
    Brinkhous KM; Read MS
    Blood; 1980 Mar; 55(3):517-20. PubMed ID: 6965594
    [No Abstract]   [Full Text] [Related]  

  • 3. Venom coagglutinin for detection of von Willebrand factor activity in animal plasmas.
    Read MS; Potter JY; Brinkhous KM
    J Lab Clin Med; 1983 Jan; 101(1):74-82. PubMed ID: 6600265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand syndrome induced by a Bothrops venom factor: bioassay for venom coagglutinin.
    Brinkhous KM; Barnes DS; Potter JY; Read MS
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3230-4. PubMed ID: 6789334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex.
    Brinkhous KM; Read MS; Fricke WA; Wagner RH
    Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1463-6. PubMed ID: 6402781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of platelet-aggregating von Willebrand factor: applications of the venom coagglutinin vWF assay.
    Brinkhous KM; Read MS; Reddick RL; Griggs TR
    Ann N Y Acad Sci; 1981; 370():191-204. PubMed ID: 7023318
    [No Abstract]   [Full Text] [Related]  

  • 7. Determinants of von Willebrand factor activity elicited by ristocetin and botrocetin: studies on a human von Willebrand factor-binding antibody.
    Brinkhous KM; Fricke WA; Read MS
    Semin Thromb Hemost; 1985 Oct; 11(4):337-41. PubMed ID: 2416059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
    Allain JP; Cooper HA; Wagner RH; Brinkhous KM
    J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation.
    Serrano SMT; Wang D; Shannon JD; Pinto AFM; Polanowska-Grabowska RK; Fox JW
    FEBS J; 2007 Jul; 274(14):3611-3621. PubMed ID: 17578514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of 2-mercaptoethanol on von Willebrand factor and bovine platelet aggregating factor.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Feb 1-15; 17(3-4):443-52. PubMed ID: 6966083
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of ristocetin and von Willebrand factor.
    Jenkins CS; Meyer D; Larrieu MJ
    Thromb Haemost; 1976 Jun; 35(3):752-3. PubMed ID: 1086517
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.
    Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R
    Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
    Gjønnaess E; Solum NO; Brosstad F
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botrocetin- and polybrene-induced platelet aggregation in platelet-type von Willebrand disease.
    Takahashi H; Nagayama R; Hattori A; Shibata A
    Am J Hematol; 1985 Feb; 18(2):179-89. PubMed ID: 3871585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ristocetin and von Willebrand factor analysis.
    Light J; Williams CE; Entwistle MB
    Med Lab Sci; 1987 Jul; 44(3):272-9. PubMed ID: 3501515
    [No Abstract]   [Full Text] [Related]  

  • 17. Nature of von Willebrand factor: a new assay and a specific inhibitor.
    Sarji KE; Stratton RD; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):2937-41. PubMed ID: 4547258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor.
    Cooper HA; Bennett WP; White GC; Wagner RH
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1433-7. PubMed ID: 7041120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelets.
    Yoshida E; Fujimura Y; Miura S; Sugimoto M; Fukui H; Narita N; Usami Y; Suzuki M; Titani K
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1386-92. PubMed ID: 8466514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.